Eli Lilly and Company today announced detailed results from two late-phase trials showing that people with obesity maintained their weight loss long term with either Foundayo or lower-dose Zepbound ...

REGULATED INFORMATIONNyxoah Reports First Quarter 2026 Financial and Operating ResultsStrong Genio launch in the U.S. drove 25% sequential ...

Recognition highlights strong clinical progress and growing global validation of Incannex’s innovative approach to treating obstructive sleep apnea ...

Children were more likely to undergo an evaluation if they had public insurance, had a higher BMI, had English as a primary ...

The global Anti-snoring Devices Market size is projected to grow at a CAGR of 8% over the next five years. The increasing ...

Alesis LLC, the U.S. distributor of the Alesis OSA1tm medical device and headquartered on Florida's Space Coast in Cocoa Beach, today announced a joint venture partnership with Lake Norman Pulmonary & ...

Alesis LLC, the U.S. distributor of the Alesis OSA1™ medical device and headquartered on Florida’s Space Coast in Cocoa Beach ...

A model made using machine learning can predict if CPAP use in patients with obstructive sleep apnea will benefit or harm ...

Detailed price information for Mineralys Therapeutics Inc (MLYS-Q) from The Globe and Mail including charting and trades.

New research to be presented at this year's European Congress on Obesity (ECO 2026, Istanbul, Turkey, 12-15 May) shows that, ...

Researchers say one of the world’s most common sleep disorders could be affecting far more than just your breathing and ...

New research presented at the European Congress on Obesity (ECO 2026, Istanbul, Turkey, 12–15 May) shows that, following ...